Singapore: Austrianova secures US$100m investment commitment from GEM

Biotech company, Austrianova, has signed an agreement with GEM Global Yield for a share subscription facility of up to US$100m for a 36-month term following a public listing. GEM is a Luxembourg based private US$3.4bn alternative investment group. The share subscription facility will allow Austrianova to draw down funds by issuing shares of common stock…

You must be a HMI Subscriber to view this content.

Subscribe Now »